CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
SGT-53 and gemcitabine/nab-paclitaxel in patients with metastatic pancreatic cancer. The objective of the study is to evaluate the ...
Phase 2
Dallas, Texas, United States
Subjects will be offered the opportunity to participate in a randomized, controlled, 2-arm, unblinded multicenter trial (RCT). There will be 2 study...
Phase 3
Dallas, Texas, United States and 5 other locations
ONIVYDE + LV + 5-FU chemotherapy regimen in patients with advanced pancreatic cancer and to determine the recommended dose for the ...
Phase 1, Phase 2
Dallas, Texas, United States and 27 other locations
open label, multi-center, clinical study of Chimeric Antigen Receptor T Cells (CAR-T) targeting claudin18.2 in patients with advanced gastric, pancreatic...
Phase 1, Phase 2
Dallas, Texas, United States and 15 other locations
Pancreatic cancer is difficult to diagnose early. By the time people have been diagnosed, the cancer has usually spread to ...
Phase 3
Dallas, Texas, United States and 33 other locations
study will assess the safety and efficacy of VS-7375 alone and in combination with cetuximab in patients with metastatic KRAS G12D - mutated Pancreatic...
Phase 2
Fort Worth, Texas, United States and 10 other locations
This phase II study evaluates how well pemigatinib works for the treatment of adult patients with pancreatic cancer that has spread...
Phase 2
Dallas, Texas, United States and 108 other locations
phosphorylase (MTAP)-deleted gastrointestinal, biliary tract, or pancreatic cancers. The study also aims to determine the safety...
Phase 1
Irving, Texas, United States and 76 other locations
The purpose of this study is to evaluate the safety and efficacy of an investigational RAS(ON) inhibitor administered as monotherapy or in combinatio...
Phase 3
Dallas, Texas, United States and 12 other locations
This study will help find the most suitable dose of ASP546C in people with gastric cancer, gastroesophageal junction (GEJ) cancer, ...
Phase 1, Phase 2
Irving, Texas, United States and 11 other locations
Clinical trials
Research sites
Resources
Legal